期刊文献+

胸苷酸合成酶基因多态性与肺癌易感性关系 被引量:2

Association between thymidylate synthase gene polymorphism and lung cancer susceptibility
原文传递
导出
摘要 目的探讨胸苷酸合成酶(TS)基因多态性与肺癌易感性的关系。方法应用聚合酶链式反应(PCR)方法检测青岛地区原发性肺癌患者473例及健康对照641人的TS 5’-非翻译区(untranslated region,UTR)多态性分布,以非条件logistic回归模型分析TS基因多态性与肺癌易感性的关系。结果 TS 5’-UTR的3种基因型3R/3R、2R/3R、2R/2R在病例组的频率分别为62.2%、34.0%和3.8%,在对照组中则分别为60.5%、37.0%和2.5%,分布差异无统计学意义(P>0.05);以携带TS 5’-UTR 3R/3R基因型者为参照,携带TS 5’-UTR 2R/3R基因型者发生肺癌的风险减少,OR值为0.90(95%CI=0.69~1.17),而携带TS 5’-UTR 2R/2R基因型者发生肺癌风险增加,OR值为1.64(95%CI=0.80~3.38),但差异均无统计学意义(P>0.05);以性别、年龄、吸烟、饮酒、病理类型,临床分期分层分析结果表明,TS 5’-UTR基因多态性与肺癌易感性无明显关联(均P>0.05)。结论 TS 5’-UTR多态与肺癌易感性无显著关联,未发现该基因多态性与吸烟、饮酒存在明显的交互作用。 Objective To study the relationship between the polymorphism in the 5'-untranslated region(5'-UTR) of thymidylate synthase(TS) gene and the susceptibility of lung cancer. Methods We conducted a case-control study with 473 lung cancer patients and 641 healthy controls in Qingdao population.The TS 5'-UTR tandem repeat genotype was analyzed with polymerase chain reaction.Unconditional logistic regression was used to analyze the relationship between TS 5'-UTR polymorphism and lung cancer susceptibility. Results The frequency of TS 5'-UTR genotypes(3R/3R,2R/3R,2R/2R) was 62.2%,34.0%,and 38% in the lung cancer patients and 60.5%,37.0%,and 2.5% in the controls,respectively.Compared with TS 5'-UTR 3R/3R genotype,2R/3R genotype showed a decreased risk of lung cancer(odds ratio=0.90,95%confidence interval:0.69-1.17),while 2R/2R genotype showed an increased risk(OR=1.64,95%CI:0.80-3.38).However,the results did not reach statistical significance(P0.05).After adjusting for age,gender,smoking,alcohol use,and histological type and stage,no significant effect of the TS 5'-UTR polymorphism was found in each subgroup. Conclusion There was no evidence for a major role of the polymorphism of TS 5'-UTR in carcinogenesis of lung cancer by genotype alone and no obvious interaction was found between smoking,alcohol use and the polymorphism in lung cancer development.
出处 《中国公共卫生》 CAS CSCD 北大核心 2011年第11期1378-1380,共3页 Chinese Journal of Public Health
基金 国家教育部留学回国人员科研启动基金项目 山东省卫生厅项目(HW044) 山东省科技发展计划项目(2010GWE202-60) 青岛科技计划项目(06-2-2-5-nsh-1)
关键词 胸苷酸合成酶 肺肿瘤 基因多态性 易感性 thymidylate synthase lung neoplasm genetic polymorphism susceptibility
  • 相关文献

参考文献13

  • 1苏佳,牛润桂,韩小友,刘力,史建平,卫国荣,陈传炜,俞顺章,姜庆五,张作风,穆丽娜.肺癌易感性与Ⅱ相代谢酶基因多态性关系[J].中国公共卫生,2009,25(4):458-460. 被引量:4
  • 2Carreras CW,Santi DV. The catalytic mechanism and structure of thymidylate synthase [J]. Annu Rev Biochem,1995,64(7) :721 -762.
  • 3Nief N, Le Morvan V, Robert J. Involvement of gene polymorphisms of thymidylate synthase in gene expression, protein activity and anticancer drug cytotoxicity using the NCI-60 panel [ J ]. Eur J Cancer,2007,43 ( 5 ) :955 - 962.
  • 4Ulrich CM, Curtin K, Potter JD, et al. Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer[J]. Cancer Epidemiol Biomarkers Prev, 2005,14 ( 11 ) :2509 - 2516.
  • 5Kim HN, Lee IK, Kim YK, et al. Association between folate-me- tabolizing pathway polymorphism and non-Hodgkin lymphoma [J]. Br J Haematol ,2008,140(3 ) :287 - 294.
  • 6Pastmus PE,Brambilla E,Chansky K,et al. The IASLC Lung CancerStaging Project:proposals for revision of the M descriptors in the forthcoming (seventh) edition of the TNM classification of lung cancer[J]. Journal Thoracic Oncology,2(X)7,2(8) :686 -693.
  • 7Horie N ,Aiba H,Oguro K,et al. Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase[ J]. Cell Structure and Function, 1995,20 (3) : 191 - 197.
  • 8Morganti M, Ciantelli M, Giglioni B, et al. Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers [ J ]. Eur J Cancer, 2005,41 (14) :2176 -2183.
  • 9Kawakami K, Salonga D, Park JM, et al. Different lengths of a polymorphic repeat sequence in the thymidylate synthase gene affect translational efficiency but not its gene expression [ J ]. Clin Cancer Res,2001,7 ( 12 ) :4096 - 4101.
  • 10Miyoshi T, Kondo K, Fujino H, et al. Thymidylate synthase and dihydropyrimidine dehydrogenase in non-small-cell lung cancer: relationship between mRNA expression and activity [ J ]. Anticancer Res ,2005,25 (2A) :923 - 930.

二级参考文献13

  • 1Lawson KA, Woodson K, Virtamo J, et al. Association of the NAD(P) H: quinone oxidoreductase ( NQO1 ) 609C→T polymorphism with lung cancer risk among male smokers[J]. Cancer Epi Bio Prev,2005,14(9) :2275 -2276.
  • 2Yang M, Choi Y, Hwangbo B, et al. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility [ J]. Lung Cancer,2007,57: 135 - 142.
  • 3Traver RD, Horikosh T, Danenberg KD, et al. NAD(P) H: quinine oxidoreductase gene expression in human colon carcinoma cells:characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity [ J ]. Cancer Res, 1992,52 ( 4 ) : 797 - 802.
  • 4Saldivar SJ, Wang YF, Zhao H, et al. An association between a NQO1 genetic polymorphism and risk of lung cancer[ J]. Mutation Res ,2005,582:71 - 78.
  • 5Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinine oxidoreductase 1 [ J]. Proc Natl Acad Sci ,2001,89 : 1188 - 1193.
  • 6Yin L,Pu Y, Liu TY, et al. Genetic polymorphisms of NAD (P) H: quinone oxidoreductase, CYP1 A1, and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China [ J ]. Lung Cancer,2001,33 : 133 - 141.
  • 7Chan EC,Lam SY,Fu KH,et al. Polymorphisms of the GSTM1, GSTP1 ,MPO,XRCC1 ,and NQ01 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes[ J]. Cancer Genetics and Cytogenetics ,2005,162 : 10 - 20.
  • 8Alexandrie AK, Nyberg F, Warholm M, et al. Influence of CYP1 A1 ,GSTM1 ,GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population[J]. Cancer Epi Bio Prev,2004,13(6) :906 -914.
  • 9Lewis SJ,Cherry NM, Niven RM, et al. Polymorphisrns in the NAD(P) H :quinone oxidoreductase gene and small cell lung cancer risk in a UK population[ J]. Lung Cancer,2001,34 : 177 - 183.
  • 10Sorensen M, Autrup H, Tjonneland A, et al. Genetic polymorphisms in CYP1B1, GSTA1 ,NQO1 and NAT2 and the risk of. lung cancer[ J]. Cancer Letters,2005,221 : 185 - 190.

共引文献3

同被引文献15

  • 1Balboa-Beltrán E,Cruz R,Carracedo A,et al.Delimiting allelic imbalance of TYMS by allele-specific analysis[J].Medicine,2015;94(27):e1091.
  • 2Goff LW,Thakkar N,Du L,et al.Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers[J].PLoS ONE,2014;9(9):e107424.
  • 3Avallone A,Gennaro ED,Silvestro L,et al.Targeting thymidylate synthase in colorectal cancer:critical re-evaluation and emerging therapeutic role of raltitrexed[J].Expert Opin Drug Saf,2014;13(1):113-29.
  • 4Jagielska EB,Ucienniczak AP,Browska MD,et al.Trichinella pseudospiralis vs.T.spiralis thymidylate synthase gene structure and T.pseudospiralis thymidylate synthase retrogene sequence[J].Parasit Vectors,2014;7(1):64-8.
  • 5Dunna NR,Naushad SM,Vuree S,et al.Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyl transfarase C1420T polymorphisms with susceptibility to acute leukemia[J].Asian Pac J Cancer Prev,2014;15(4):1719-23.
  • 6Shintani Y,Ohta M,Hirabaynshi H,et al.New prognostic indicator for non-small-cell lung cancer,quantitation of thymidylate synthase by realtime reverse transcription polymemse chain reaction[J].Int J Cancer,2003;104(6):790-5.
  • 7Mandola MV,Stochlmaeher J,Zhang W,et al.A 6 bp polymorphism in the thymidylate synthase gene causes message instability and is associated with decreased intratumoral TS mRNA levels[J].Pharmacogenetics,2004;14(3):319-27.
  • 8Assinri D,Scarpi E,Saqrtori S,et al.Second-line treatments in nonsmall cell lung cancer:a systematic reviews of literature and metaanalysis of randomized clinical trials[J].Chest,2009;135(6):1596-609.
  • 9Tanaka F,Wada H,Fukui Y,et al.Thymidylate synthase(TS)gene expression in primary lung cancer patients:a large-scale study in Japanese population[J].Ann Oncol,2011;22(8):1791-7.
  • 10于飞,刘晓晴,李晓燕,李俭杰,郭万峰,秦海峰,高红军.培美曲塞单药或联合铂类三线及以上治疗晚期非鳞型非小细胞肺癌的临床观察[J].中国肺癌杂志,2012,15(2):117-121. 被引量:33

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部